De-escalation in definitive surgical management for cervical cancer

The surgical management of early-stage cervical cancer has evolved from routine radical hysterectomy to more tailored, less invasive approaches. Historical innovations established radical hysterectomy as a cornerstone of cervical cancer treatment, but recent evidence has challenged its necessity in selected low-risk patients. Prospective and randomized controlled trials, including the ConCerv and Simple Hysterectomy and Pelvic Node Assessment (SHAPE) studies, support the safety of simple hysterectomy in tumors ≤2 cm with favorable pathological features, demonstrating similar oncologic outcomes and reduced morbidity. Sentinel lymph node biopsy has emerged as a reliable alternative to full lymphadenectomy, with high diagnostic accuracy and lower complication rates. The intra-operative abandonment of radical surgery upon detection of nodal metastasis appears to avoid overtreatment without affecting survival. Finally, preoperative brachytherapy, though associated with higher local control and reduced need for adjuvant external beam radiotherapy, remains investigational pending results from high-quality randomized controlled trials. Current guidelines reflect some of these evolving strategies, recommending fewer radical procedures and sentinel node mapping for selected patients. This paradigm shift emphasizes individualized surgical planning, balancing oncologic efficacy with quality of life, and underscores the ongoing refinement of cervical cancer care in the modern era.